Aspirin cuts liver fat in clinical trial
The most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an increased buildup of fat in the liver due to factors such as obesity and type 2 diabetes.
Mar 25, 2024
0
47